Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID07189234

TIMET 2.0 - Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health

Led by University of California, San Diego · Updated on 2026-02-02

140

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

Sponsors

U

University of California, San Diego

Lead Sponsor

S

Salk Institute for Biological Studies

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying the effects of time-restricted eating (TRE) on patients with metabolic syndrome who have high blood pressure and at least two other metabolic risk factors, such as increased waist size, abnormal cholesterol, high triglycerides, or elevated fasting glucose. The study focuses on people who typically eat for more than 12 hours daily and aims to better understand how limiting eating to a 10-hour window daily may impact cardiometabolic health over a long period. Participants are randomly assigned to one of two groups: one follows a daily 10-hour eating window combined with standard care and nutritional counseling, while the other continues their usual lifestyle without the eating window but also receives nutritional counseling. The study lasts 54 weeks and involves logging all food and drink intake using a smartphone app. Both groups receive lifestyle coaching and track their calories using the app. Throughout the study, researchers will measure height, weight, waist size, and blood pressure. Blood tests will check blood sugar control, insulin, lipids, and detailed cholesterol profiles. Participants will wear a continuous glucose monitor and an activity tracker at the start, six months, and the end of the study to monitor blood sugar, physical activity, and sleep. Body composition will be evaluated by DEXA scans, and an oral glucose tolerance test will assess how the body handles sugar. The main outcome is change in glucose levels after 54 weeks, along with other measures like cholesterol, insulin sensitivity, bone density, muscle mass, and body fat.

CONDITIONS

Brief Title

Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 75 years
  • HbA1c between 5.7% and 7.0%
  • Diagnosis of metabolic syndrome meeting at least three criteria: elevated blood pressure (≥130/85 mm Hg or on antihypertensive therapy), increased waist circumference (≥90 cm men/≥80 cm women for Asians; ≥102 cm men/≥88 cm women for others), fasting triglycerides ≥150 mg/dL or treatment for elevated triglycerides, reduced HDL-cholesterol (<40 mg/dL men, <50 mg/dL women) or treatment for reduced HDL, fasting glucose ≥100 mg/dL
  • Own a smartphone with Apple iOS or Android operating system
  • Baseline daily eating period of 12 hours or more
  • Stable dose of cardiovascular medications (e.g., statins, lipid-modifying drugs, antihypertensives) for at least 1 month
  • Stable doses of GLP-1 receptor agonists, SGLT2 inhibitors, or Metformin for at least 3 months
Not Eligible

You will not qualify if you...

  • Use of sulfonylurea or insulin
  • HbA1c greater than 7.0%
  • Pregnancy or breastfeeding; pregnancy test required for those of reproductive age before DEXA scan
  • Caregivers requiring frequent nocturnal care or sleep interruptions
  • Shift workers with variable or night shifts
  • Frequent travel across time zones during the study
  • Active tobacco use, illicit drug use, or history of treatment for alcohol abuse
  • Major cardiovascular event within the past year (e.g., heart attack, stroke, heart surgery, heart failure hospitalization)
  • Weight management surgery within the past 2 years or longer if unsafe
  • Uncontrolled arrhythmia (rate-controlled atrial fibrillation/flutter allowed)
  • Recent thyroid disease requiring medication dose changes
  • History of adrenal disease
  • Active cancer treatment except non-melanoma skin cancer
  • Known type 1 diabetes
  • History of eating disorder
  • History of cirrhosis
  • Advanced kidney disease stage 4 or 5 or dialysis
  • Currently enrolled in a weight-loss program
  • Following a special or prescribed diet (e.g., Celiac disease)
  • Uncontrolled psychiatric disorder or hospitalization for psychiatric illness
  • Unable or unwilling to use the smartphone app throughout the study duration

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Outpatient Treatment

Duration - 54 weeks

Participants follow a behavioral intervention where they either adhere to a daily, consistent 10-hour eating window with nutritional counseling or maintain their current lifestyle with nutritional counseling and track caloric intake using a smartphone app. They use the app throughout the study to log all food and beverage intake.

Regular meetings with a dietician and periodic assessments including blood tests, body measurements, and device wear at baseline, 6 months, and 12 months

Follow-up

Duration - Up to 12 months total from study start

Participants continue to be monitored for changes in cardiometabolic health parameters after the active intervention period.

Device-based monitoring with continuous glucose monitors and actigraphy devices worn for 2 weeks at baseline, 6 months, and 12 months

Trial Site Locations

Total: 1 location

1

Altman Clinical and Translational Research Institute

La Jolla, California, United States, 92093

Actively Recruiting

Loading map...

Research Team

G

Gavin McLaren

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Nutritional Approach for the Transformation and Reduction of...

Metabolic Syndrome

Actively Recruiting

1 location

Primary Prevention Study of Cardiovascular Diseases and Diab...

Metabolic Syndrome

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial